Multiple Sclerosis and Pregnancy
29 Mar 2019
A new study challenges the belief that women with Multiple Sclerosis experience relapse right after pregnancy. This new study shows that this theory is not true. An experiment was conducted on pregnant women with MS who did not receive any treatment during the year of pregnancy. The relapse rate for women before pregnancy is less than the relapse rate for women after pregnancy. Interferon-betas and glatiramer acetate were the most commonly used medications used by women who resumed treatment. Women with MS can easily conceive without a risk of relapse during the postpartum period. These findings will be presented at American Academy of Neurology’s annual meeting in Philadelphia in May.